EGFR and hepatocellular carcinoma: EGFR is highly expressed in 40–70% of HCC patients, and it has been shown that HCC patients with EGFRhigh have a poor prognosis and have a shorter survival time than those with low EGFR expression (EGFRlow) (12, 13).